Chronic Shoulder Pain
Conditions
Brief summary
Aim of This study is to compare between the effect of ultrasound-guided local injection of Platelet Rich Plasma (PRP)versus Hyaluronic (HA) for the treatment of chronic shoulder pain.
Detailed description
This study was prospective randomized comparative trial on patients with chronic shoulder pain presented at outpatient Clinic of Physical Medicine, Rheumatology and Rehabilitation Department at Assiut University Hospitals from June 2019 to December 2020. Our study started by 70 patient with chronic shoulder pain 20 of them were missed in follow up period, the range of age from 36 - 56 years, history, clinical examination, Laboratory investigation, and imaging (X-ray or MRI) done for all patient to complete the diagnosis, patient divided randomly into two groups, Group (A) included 25 patients were treated by PRP injection and group (B) included 25 patients were treated by HA injection, both injections were performed under ultrasound (US) guidance. Randomization by sealed envelopes technique, the follow up was at the baseline, 4 weeks and 6 months post injection.
Interventions
PROCEDUREplatelet rich plasm
local injection of shoulder joint by platelet rich plasm
PROCEDUREHyaluronic acid
local injection of shoulder joint by Hyaluronic acid
Sponsors
Assiut University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No
Inclusion criteria
* Adult patient age \>18 years. * Patients with chronic shoulder pain more than 6 months not responding to medical treatment or physical therapy. * Frozen shoulder. * Rotator cuff disorders (partial tear).
Exclusion criteria
* Shoulder joint instability or traumatic shoulder pain. * Patients with local infection at the shoulder, systemic infection, or inflammatory disease (e.g., rheumatoid arthritis and hepatitis) * Patients with a history of diabetes mellitus and malignancy (either hematological or non-hematological). * Pregnancy. * Patients on anticoagulant therapy. * Injection of shoulder with corticosteroids in the preceding 6 months.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Visual Analogue Scale (VAS) | 4weeks post injection follow up. | 0-10 visual analogue scale of pain |
| Shoulder Pain and Disability Index (SPADI) questionnaire | 4weeks post injection follow up. | is a self-introduction administered index designed to measure the effects of different pathologic conditions on the functional status of the shoulder. All items are rated by using a visual analogue scale from no pain or no difficulty to worst imaginable pain or so difficult it required help. A numerical value was obtained by dividing the scale into 11 segments from 0 to 10 for each item |
| Constant score (CS) | 4weeks post injection follow up. | This scoring system combines physical examination tests with subjective evaluations by the patients. The subjective assessment consists of 35 points and the remaining 65 points are assigned for the physical examination assessment. The subjective assessment includes a single item for pain (15 points) and 4 items for activities of daily living (20 points) (work 4, sport 4, sleep2 and positioning the hand in space 10 points). The objective assessment includes: range of motion (40 points) (forward elevation, 10 points; lateral elevation, 10 points; internal rotation, 10 points; external rotation, 10 points) and power (25 points) (scoring based on the number of pounds of pull the patient can resist in abduction to a maximum of 25 points). The total possible score is therefore 100 points. |
Countries
Egypt
Outcome results
None listed